Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Viewpoint
Nature Reviews Clinical Oncology 2, 596–597 (1 December 2005) | doi:10.1038/ncponc0360
The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer
&
Abstract
Substantial progress has been made using aromatase inhibitors in early-stage breast cancer. This article highlights results from recent and ongoing trials of aromatase inhibitors as adjuvant therapy and discusses options for integration of these agents with tamoxifen in various subsets of patients and clinical scenarios.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
